Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02431260
Title An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Incyte Corporation
Indications

Advanced Solid Tumor

lymphoma

Therapies

INCB054329

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
University of California, San Francisco, Medical Center at Mount Zion San Francisco California 94115 United States Details
Sarah Cannon Research Institute Research Center Denver Colorado 80218 United States Details
Northwestern Memorial Hospital Chicago Illinois 60611 United States Details
The University of Chicago Medical Center Chicago Illinois 60637 United States Details
Horizon Oncology Center Lafayette Indiana 47905 United States Details
John Hopkins Baltimore Maryland 21287-0013 United States Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
Washington University School of Medicine in St. Louis Saint Louis Missouri 63110 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232-0021 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field